{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-127475","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.281769+00:00","generated_at":"2026-06-21T03:20:31.712587+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Hepion shareholders approve reverse stock split; Board to set ratio 1:2 to 1:20","bullets":["Special meeting held Dec 15, 2022; proposal to amend charter for reverse split approved.","Vote: 6,757,528,739 for, 3,262,017,173 against, 38,856,945 abstained; 0 broker non-votes.","Board authorized to select ratio between 1:2 and 1:20 within one year of meeting.","Proposal covers all outstanding common and preferred shares as of Nov 8, 2022 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-127475","json":"https://secwatch.observer/filing/0001104659-22-127475.json","markdown":"https://secwatch.observer/filing/0001104659-22-127475.md","text":"https://secwatch.observer/filing/0001104659-22-127475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/0001104659-22-127475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/tm2232810d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:20:31.712587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d8bc32fc1d23070d97d93670f2fd9beef74fa07","claim":"Hepion Pharmaceuticals, Inc. shareholders approved Adoption and approval of an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock at a ratio ranging from 1:2 to 1:20, with the exact ratio determined by the Board at the 2022-12-15 meeting.","evidence_excerpt":"The proposal to adopt and approve an amendment to the Charter to effect a reverse stock split of the Company’s issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-twenty (1:20), at any time prior to the one-year anniversary date of the Special Meeting, with the exact ratio to be determined by the Board was approved by a majority of the voting power of the outstanding shares of Common Stock, Series A Preferred Stock Series F Preferred Stock and Series G Preferred Stock entitled to vote on the proposal, based upon the following votes: Votes For Votes Against Votes Abstained Broker Non-Vote 6,757,528,739 3,262,017,173 38,856,945 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/0001104659-22-127475-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}